Christiaan Mulder
Biographic Data
| ID | 5837885 |
|---|---|
| NAME | Christiaan Mulder |
| GIVEN NAMES | Christiaan |
| FAMILY NAME | Mulder |
| SIGNATURE | MULDER C |
| AFFILIATIONS | TuBerculosis Vaccine Initiative |
| ORCID | 0000-0003-2628-7460 |
| VERIFIED | Yes |
| TOTAL WORKS | 6 |
| TOTAL CITATIONS | 0 |
| WORKS AS AUTHOR | 6 |
| WORKS AS EDITOR | 0 |
| FIRST PUBLICATION YEAR | 2021 |
| LATEST PUBLICATION YEAR | 2026 |
| H-INDEX | 0 |
Feasibility and acceptability of Covid-19 self-testing offered through community screening posts in Mozambique
COVID-19 self-testing is a key strategy for point-of-care testing and COVID-19 outbreak management to identify people infected with SARS-CoV-2 in low- and middle-income settings. We assessed the feasibility and acceptability of healthcare worker-supervised COVID-19 self-tests at community bi-directional screening posts for COVID-19 and tuberculosis in urban and peri-urban areas in southern Mozambique. Between May and August 2023, Persons presenti…
An evaluation of a choice architecture-based intervention on prescribing of TB preventive treatment to people living with HIV in southern Africa (the CAT study)
INTRODUCTION: While highly effective for reducing the risk of tuberculosis (TB) disease, TB preventive treatment (TPT) is underused among people living with HIV (PWH). We evaluated the effectiveness of a behavioural economics-based choice architecture approach to increase facility-level TPT prescribing to PWH in Malawi, Mozambique and Zimbabwe. METHODS: We conducted a cluster-randomised trial within the IMPAACT4TB 3HP rollout, in which 57 healthc…
Cost and cost-effectiveness of pediatric home-based versus facility-based TB Preventive Treatment in Ethiopia (CHIP-TB)
Tuberculosis preventive treatment (TPT) is an essential intervention recommended for all child contacts in Ethiopia under 15 years who are at risk of tuberculosis (TB) infection. We conducted a cost and cost-effectiveness analysis of home-based versus facility-based TPT provision for child contacts in Ethiopia. As part of the CHIP TB trial, a pragmatic, cluster-randomized trial conducted at eighteen clinics in Ethiopia, clinics were randomized to…
Trends in the availability and prices of quality-assured tuberculosis drugs
BACKGROUND: The Global Drug Facility (GDF) of the Stop TB Partnership was launched in 2001 with the goal of increasing access to quality-assured tuberculosis (TB) drugs and products. We aimed to describe the TB drugs and prices available from the GDF over time and to assess trends. METHODS: We searched the internet, including an internet archive, for past and recent GDF Product Catalogs and extracted the listed TB drugs and prices. We calculated …
Budgetary impact of using BPaL for treating extensively drug-resistant tuberculosis
INTRODUCTION: Bedaquiline, pretomanid and linezolid (BPaL) is a new all oral, 6-month regimen comprised of bedaquiline, the new drug pretomanid and linezolid, endorsed by the WHO for use under operational research conditions in patients with extensively drug-resistant tuberculosis (XDR-TB). We quantified per-patient treatment costs and the 5-year budgetary impact of introducing BPaL in Indonesia, Kyrgyzstan and Nigeria. METHODS: Per-patient treat…
Acceptability, feasibility, and likelihood of stakeholders implementing the novel BPaL regimen to treat extensively drug-resistant tuberculosis patients
Acceptability and feasibility of the BPaL regimen is high among TB stakeholders in Indonesia, Kyrgyzstan, and Nigeria. The majority is willing to start using BPaL as the standard of care for eligible patients despite country-specific health system constraints
No prominent works on this page.
Acceptability, feasibility, and likelihood of stakeholders implementing the novel BPaL regimen to treat extensively drug-resistant tuberculosis patients
Acceptability and feasibility of the BPaL regimen is high among TB stakeholders in Indonesia, Kyrgyzstan, and Nigeria. The majority is willing to start using BPaL as the standard of care for eligible patients despite country-specific health system constraints
Budgetary impact of using BPaL for treating extensively drug-resistant tuberculosis
INTRODUCTION: Bedaquiline, pretomanid and linezolid (BPaL) is a new all oral, 6-month regimen comprised of bedaquiline, the new drug pretomanid and linezolid, endorsed by the WHO for use under operational research conditions in patients with extensively drug-resistant tuberculosis (XDR-TB). We quantified per-patient treatment costs and the 5-year budgetary impact of introducing BPaL in Indonesia, Kyrgyzstan and Nigeria. METHODS: Per-patient treat…
Trends in the availability and prices of quality-assured tuberculosis drugs
BACKGROUND: The Global Drug Facility (GDF) of the Stop TB Partnership was launched in 2001 with the goal of increasing access to quality-assured tuberculosis (TB) drugs and products. We aimed to describe the TB drugs and prices available from the GDF over time and to assess trends. METHODS: We searched the internet, including an internet archive, for past and recent GDF Product Catalogs and extracted the listed TB drugs and prices. We calculated …
An evaluation of a choice architecture-based intervention on prescribing of TB preventive treatment to people living with HIV in southern Africa (the CAT study)
INTRODUCTION: While highly effective for reducing the risk of tuberculosis (TB) disease, TB preventive treatment (TPT) is underused among people living with HIV (PWH). We evaluated the effectiveness of a behavioural economics-based choice architecture approach to increase facility-level TPT prescribing to PWH in Malawi, Mozambique and Zimbabwe. METHODS: We conducted a cluster-randomised trial within the IMPAACT4TB 3HP rollout, in which 57 healthc…
Cost and cost-effectiveness of pediatric home-based versus facility-based TB Preventive Treatment in Ethiopia (CHIP-TB)
Tuberculosis preventive treatment (TPT) is an essential intervention recommended for all child contacts in Ethiopia under 15 years who are at risk of tuberculosis (TB) infection. We conducted a cost and cost-effectiveness analysis of home-based versus facility-based TPT provision for child contacts in Ethiopia. As part of the CHIP TB trial, a pragmatic, cluster-randomized trial conducted at eighteen clinics in Ethiopia, clinics were randomized to…
Feasibility and acceptability of Covid-19 self-testing offered through community screening posts in Mozambique
COVID-19 self-testing is a key strategy for point-of-care testing and COVID-19 outbreak management to identify people infected with SARS-CoV-2 in low- and middle-income settings. We assessed the feasibility and acceptability of healthcare worker-supervised COVID-19 self-tests at community bi-directional screening posts for COVID-19 and tuberculosis in urban and peri-urban areas in southern Mozambique. Between May and August 2023, Persons presenti…
Medicine (5 works) · Tuberculosis Research and Epidemiology (5 works) · Tuberculosis (4 works) · Bedaquiline (3 works) · Internal Medicine (3 works) · Mycobacterium tuberculosis (3 works) · Biostatistics (2 works) · Business (2 works) · Environmental health (2 works) · Family medicine (2 works)